The Missouri Pharmacy Association is examining the latest deal President Trump has reached with the pharmaceutical industry. Nine drug makers — Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi...
The proposed tariffs on prescription drugs manufactured overseas are currently on hold after President Trump and Pfizer struck a deal. Terms of the deal include a 3-year grace period for the pharmaceutical giant in exchange for investing in drug manufacturing in the...
